Corvus Pharmaceuticals, Inc. (CRVS) Files Form 4 Insider Buying : Peter A. Thompson Buys 50,000 Shares

Corvus Pharmaceuticals, Inc. (CRVS): Peter A. Thompson , director 10% owner of Corvus Pharmaceuticals, Inc. purchased 50,000 shares on Jun 9, 2016. The Insider buying transaction was reported by the company on Jun 13, 2016 to the Securities and Exchange Commission. The shares were purchased at $12.97 per share for a total value of $648,100.00 , the company said in a SEC Form 4 Filing.

Other Insider transactions have been reported by the company according to SEC Form 4, on May 24, 2016, Peter A. Thompson (director 10% owner) purchased 4,716 shares at $13.09 per share price.On May 16, 2016, Richard A Md Miller (CEO) purchased 30,300 shares at $9.97 per share price.Also, On May 16, 2016, A/s Novo (10% owner) purchased 70,000 shares at $10.00 per share price.

Company has been under the radar of several Street Analysts.Corvus Pharmaceuticals, Inc. is Initiated by Credit Suisse to Outperform. The Rating was issued on Apr 18, 2016.Corvus Pharmaceuticals, Inc. is Initiated by Guggenheim to Buy. The Rating was issued on Apr 18, 2016.

Leave a Reply

Corvus Pharmaceuticals, Inc. - Is it time to Sell?

Top Brokerage Firms are advising their investors on Corvus Pharmaceuticals, Inc.. Subscribe to MoneyFlowIndex.Org Pre-Market Alerts, You will be the first to know the street buzz.